Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-14

Clinical Trial Update: Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial exploring whether the mitochondrial protective agent idebenone can prevent post-stroke epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Idebenone (idebenone)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Post Stroke Epilepsy | Phase 4 | Status: UNKNOWN